Here are five takeaways:
1. An aging population, increasing number of patients with chronic back pain, rising awareness of chronic pain and a growing number of technologies will drive the market’s growth.
2. Cost and unfavorable reimbursement policies will serve as obstacles to the market’s growth.
3. North America and Europe hold the largest shares of the market.
4. Asia will experience the fastest market growth because of better reimbursement policies, a large population, more awareness of technologies and increased purchasing power of hospitals.
5. Medtronic, Stryker, Pioneer Surgical, NuVasive, DuPuy Spne, Globus Medical, K2M, Orhtofix International, TranS1, Amedica, Zimmer, LDR, Biomet Spine, Exactech, Integra LifeSciences, Alphatec Spine, Orthovita and Synthes lead the market.
More articles on devices:
Ellipse Technologies files $75M IPO: 4 takeaways
National Association of Professional Women honors NuVasive’s Heather Rossetti: 4 quick facts
Xtant Medical stock listed on NYSE MKT: 3 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
